<DOC>
	<DOC>NCT00161681</DOC>
	<brief_summary>The purpose of this study is to determine whether LNG/EE is effective in the treatment of menstrual cycle related symptoms.</brief_summary>
	<brief_title>Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS</brief_title>
	<detailed_description />
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy women aged 18 to 49 years Regular 21 to 35 day menstrual cycles for 3 months prior to study visit 1 History of menstrual cycle related symptoms as determined by the investigator. Contraindication to combination oral contraceptives Depression requiring hospitalization or associated with suicidal ideation within the last 3 years Use of antidepressants/anxiolytics within 10 days of screening and for the duration of the study.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Levonorgestrel</keyword>
	<keyword>ethinyl estradiol</keyword>
	<keyword>premenstrual syndrome</keyword>
	<keyword>menstrual cycle related symptoms</keyword>
</DOC>